Transplantation Technologies & Research

Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan

Publications

• Mini Review   
  Survival in Hematopoietic Stem Cell Transplantation Recipients with Autoimmune Diseases Infected with COVID-19
  Author(s): Joseph Patrick*
  
  These patients face a delicate balance as HSCT suppresses their immune system to prevent disease relapse but leaves them vulnerable to infections, including the novel coronavirus. The knowledge gap concerning the impact of COVID-19 on HSCT recipients with ADs is particularly concerning. While there is a wealth of information on COVID-19 outcomes in the general population and even in patients with other underlying conditions, this specific subgroup remains largely uncharted territory. Data on the severity, progression, and ultimate outcomes of COVID-19 in these individuals are still sorely lacking. In an effort to address this void, we present a summary of eleven cases in which individuals who had undergone HSCT for ADs contracted COVID-19. These cases offer valuable insights into the potential risks, disease course, and outcomes... Read More»
  DOI: 10.37421/2161-0991.2023.13.232

  Abstract HTML PDF